Remarkably, in this 3D set-up, the transduction efficiency of targeting to the original receptor (i.e. CAR) resulted in comparable numbers of transduced tumor cells as with EGFR- and EpCAM-retargeted viruses. The gene discussed is EPCAM; the disease is neoplasm.